JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Tumor Market Research Reports

To refine your search by industry, market, geographic region, country or price, use Advanced Search or contact Client Services for assistance.

1
2

Report Title

Published

Price

Primitive Neuroectodermal Tumor (PNET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

May 28, 2022

$2,000.00
Tumor Necrosis Factor Ligand Superfamily Member 4 (Glycoprotein Gp34 or OX40 Ligand or TAX Transcriptionally Activated Glycoprotein 1 or CD252 or TNFSF4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Player

May 31, 2022

$2,500.00
Benign Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

June 13, 2022

$2,000.00
Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

June 14, 2022

$2,000.00
Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

June 17, 2022

$2,000.00
Pituitary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

June 18, 2022

$2,000.00

1
2

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

Custom Research

Contact us to speak
with your industry analyst.

[email protected]
+1 212 564 2838

Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838

Browse All Reports